curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page
Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial

Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two immunotherapies …  Researchers conducting a clinical trial of...
Expanded Access Program for recombinant BCG launches at first US site

Expanded Access Program for recombinant BCG launches at first US site

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  There are also 60 sites in the process of launching the EAP.  There are also 60 sites in the process of launching the EAP. 
20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support

20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  20/20 Onsite is proud to announce its recognition with the Safety Excellence Award by Whip Around.  20/20 Onsite is proud to announce its recognition with the Safety Excellence Award by Whip Around. 
Cantargia enrols first patient in trial of nadunolimab for AML and MDS

Cantargia enrols first patient in trial of nadunolimab for AML and MDS

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals with AML and MDS.  Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals with AML and...
Parents’ grief after Ender Nihat’s clinical trial death

Parents’ grief after Ender Nihat’s clinical trial death

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  A seven-year-old boy dies from organ failure after chemotherapy is used in an experimental treatment.  A seven-year-old boy dies from organ failure after chemotherapy is used in an experimental treatment. 
Clinical Trials Market | Trends, Growth, Size & Forecast 2024-2031 | Syneos Health, Inc., WuXi AppTec Co., Ltd, Celerion.

Clinical Trials Market | Trends, Growth, Size & Forecast 2024-2031 | Syneos Health, Inc., WuXi AppTec Co., Ltd, Celerion.

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  The Global Clinical Trials Market reached USD 56 640 7 million in 2022 and is projected to witness lucrative growth by reaching up to USD 99 212 0 million by 2031 The clinical trials market is expected to exhibit a …  The Global Clinical Trials Market reached...
« Older Entries
Next Entries »

Recent Posts

  • Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large B-Cell Lymphoma
  • Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris
  • A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)
  • Effect of Autologous Serum-Soaked Paper Patch vs. Traditional Dry Paper Patch on Tympanic Membrane Perforations
  • Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®